Adoption of the ImageXpress® Micro Confocal High-Content Imaging System enhances Sygnature Discovery’s Capabilities

Nottingham, UK – 4th July 2016 – Sygnature Discovery Limited, a company which undertakes integrated drug discovery projects for pharmaceutical and biotechnology companies worldwide, from target validation to development candidate, today announced the addition of a ‘state-of-the-art’ ImageXpress® Micro Confocal High-Content Imaging System to its Bioscience Department. This high resolution imaging system will complement and […]

Dr Simon Hirst wins prestigious Royal Society of Chemistry Award

Dr Simon Hirst, Founder & CEO of Sygnature Discovery, is the Royal Society of Chemistry’s ‘Chemistry World Entrepreneur of the Year’ 2016. The award was given for his entrepreneurship in UK Life Sciences and founding Sygnature Discovery. Simon was presented with his award at an awards ceremony in London on 15th June 2016, hosted by […]

STOP PRESS: Dr Simon Hirst wins RSC’s Entrepreneur of the Year Award 2016

15th June 2016 – London, UK – Dr Simon Hirst, Founder and CEO of Sygnature Discovery Limited, was tonight declared the winner of the prestigious Royal Society of Chemistry’s Chemistry World Entrepreneur of the Year Award 2016, sponsored by Trinity Scientific.  More details to follow …

Sygnature Discovery hosts Kinase 2016: Next Generation Inhibitors

16th & 17th May 2016 – Nottingham, UK – Sygnature Discovery sponsored and hosted the Kinase 2016: Next Generation Inhibitors symposium at BioCity Nottingham this year.  This is the first time the conference has been held in Nottingham and it was a sell-out. Over 120 delegates attended the two-day symposium which included exceptional keynote speakers, […]

Page 3 of 1012345...10...Last »
Copyright © 2017 Sygnature Discovery

Website built by AtomicMedia - Design by Freestyle.